Despite the requirement for two daily injections, patients accepted the treatment because it worked
J Biol Chem 267(11):74027405 Schirra J, Sturm K, Leicht P, Arnold R, Goke B, Katschinski M (1998) Exendin(939)amide is an antagonist of glucagon-like peptide-1(736)amide in humans
Container type matters
Este producto viene presentado en dos formatos, un envase de menor tamao que contiene 50 cpsulas y un envase mayor que contiene 180 cpsulas
it has a half-life of 11 minutes and requires 3 injections per day
This may include delaying decisions about food, substituting high calorie snacks with lighter options, improving hydration, or using distraction techniques such as walking, stretching, or starting a brief task